Sanofi India net moves up by 37.5% in Q1, Charles Billard will be new CFO

New Delhi: Drug firm Sanofi India on Tuesday reported 37.27 per cent rise in net profit to Rs 82.5 crore for the quarter ended March 31, 2018.

The company had posted a net profit of Rs 60.1 crore in January-March period of 2016-17, Sanofi India said in a filing to BSE.

Total revenue from operations also rose to Rs 617.7 crore as against Rs 552.9 crore earlier, it added.

In a separate filing , the company said its board has approved appointment of Charles Billard as Chief Financial Officer and key Managerial Personnel with effect from July 1, 2018.

Shares of Sanofi India were today trading at Rs 4,890.85 per scrip on BSE, up 1.17 per cent from its previous close.

  • Related Posts

    IIT Kanpur scientists’ research reveals how a promising vaccine booster switches on immune cells

    Kanpur: Scientists at IIT Kanpur have revealed how an experimental molecule called EP67 switches on an important receptor found on human immune cells. EP67 is a candidate “adjuvant”, an ingredient…

    Government takes steps to strengthen primary healthcare services

    The Union minister of state for health and family welfare, Prataprao Jadhav stated that the government has taken steps to strengthen primary healthcare services in the country. The ministry of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    IIT Kanpur scientists’ research reveals how a promising vaccine booster switches on immune cells

    IIT Kanpur scientists’ research reveals how a promising vaccine booster switches on immune cells

    Government takes steps to strengthen primary healthcare services

    Government takes steps to strengthen primary healthcare services

    Operation Vajra: CBN thwarts Global Syndicate, seizes 12 Crore ‘Fighter Drug’ Tablets destined for Conflict Zones

    Operation Vajra: CBN thwarts Global Syndicate, seizes 12 Crore ‘Fighter Drug’ Tablets destined for Conflict Zones

    National Health Emergency: Telangana C-section Cluster Spark Critical Alarms as Substandard Drug Suspicions spread Nationwide

    National Health Emergency: Telangana C-section Cluster Spark Critical Alarms as Substandard Drug Suspicions spread Nationwide

    Star Bio Pharma Global strengthens its position in the global nutraceutical supply Chain

    Star Bio Pharma Global strengthens its position in the global nutraceutical supply Chain

    Chemists demand fair competition in pharma market amid online sales concerns

    Chemists demand fair competition in pharma market amid online sales concerns